| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/11/2007 | EP1123094B1 Therapeutic compositions (ii) |
| 04/11/2007 | EP1019044B1 Composition and methods for treating alzheimer's disease and other amyloidoses |
| 04/11/2007 | EP0988379B1 Ldl-receptor |
| 04/11/2007 | EP0984987B1 A soluble laminin receptor precursor and methods to ihnibit its interactions |
| 04/11/2007 | CN1946726A Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 04/11/2007 | CN1946721A Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof |
| 04/11/2007 | CN1946714A Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors |
| 04/11/2007 | CN1946697A Substituted pyrazoline compounds for reducing triglycerides in blood |
| 04/11/2007 | CN1946456A Alcohol metabolism moderating composition |
| 04/11/2007 | CN1946418A Treatment of conditions involving dopaminergic neuronal degeneration using NOGO receptor antagonists |
| 04/11/2007 | CN1946400A Use of n-piperidine derivatives for the treatment of neurodegenerative pathologies |
| 04/11/2007 | CN1946399A Method of treating schizophrenia and/or glucoregulatory abnormalities |
| 04/11/2007 | CN1946398A Thiadiazolidinones as gsk-3 inhibitors |
| 04/11/2007 | CN1946395A 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors |
| 04/11/2007 | CN1946391A Combinations comprising alpha-2-delta ligands |
| 04/11/2007 | CN1946386A Combination of deramciclane and opoids as analgesics |
| 04/11/2007 | CN1944647A Dopamine receptor new sub-type D5B gene and coded protein and use |
| 04/11/2007 | CN1944448A Puerarin derivative and its medicinal use |
| 04/11/2007 | CN1943781A Orally administered peptides to ameliorate atherosclerosis |
| 04/11/2007 | CN1943774A A pharmaceutical preparation for strengthening memory |
| 04/11/2007 | CN1943757A A Chinese traditional medicinal composition for treatment of hemicrania and its preparation method |
| 04/11/2007 | CN1943752A A Medicine for treatment of netting addiction |
| 04/11/2007 | CN1943751A A health-protective pharmaceutical for activating and improving intellect and its preparation method |
| 04/11/2007 | CN1943749A A Chinese traditional medicinal composition for treatment of Child's feeblemindedness of and its preparation method |
| 04/11/2007 | CN1943724A A Chinese traditional medicinal composition for treatment of migraine and its preparation method |
| 04/11/2007 | CN1943716A A Chinese traditional medicinal composition for brain tuning and nerves soothing and its preparation method |
| 04/11/2007 | CN1943715A A Chinese traditional medicinal injection preparation and its preparation method |
| 04/11/2007 | CN1943711A A Chinese traditional medicinal composition for heart nourishment and memory strengthening and its preparation method |
| 04/11/2007 | CN1943692A Regenesis of vita source |
| 04/11/2007 | CN1943681A A Chinese traditional medicinal composition for treatment of child feeblemindedness and its preparation method |
| 04/11/2007 | CN1943673A Sedation brain refreshing liquid |
| 04/11/2007 | CN1943670A An oil cream for giving up smoke |
| 04/11/2007 | CN1943652A A Chinese traditional medicine for treatment of sciatic neuralgia and lumbocrural pain and its preparation method |
| 04/11/2007 | CN1943642A Preparing method for a kind of medicinal composition and its effective parts and active ingredients |
| 04/11/2007 | CN1943615A Use of sappan wood alcohol extract inpreparing single medicine for treating self immunological disease |
| 04/11/2007 | CN1943613A Granular agent with brain strengthening function |
| 04/11/2007 | CN1943585A Breviscapine proliposome powder preparation and its preparing method |
| 04/11/2007 | CN1943576A Buprenorphin and/or buprenorphin hydrochloride plaster substrate and its preparing method for plaster |
| 04/11/2007 | CN1943575A Abuse potential low compound buprenorphin hydrochloride naloxone hydrochloride sublingual tablet |
| 04/11/2007 | CN1943570A Use of opc in preparing medicine for treating and preventing senile dementia |
| 04/11/2007 | CN1943419A Health food and its preparing method |
| 04/11/2007 | CN1309830C Variants of TRAF2 which act as an inhibitor of TNF-alpha signaling pathway |
| 04/11/2007 | CN1309813C Oil or fat composition |
| 04/11/2007 | CN1309734C Polypeptides involved in immune response |
| 04/11/2007 | CN1309722C Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans |
| 04/11/2007 | CN1309721C Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| 04/11/2007 | CN1309717C 4-aryl group-5H-thoifuran-2-ketone derivative, producing method and use thereof |
| 04/11/2007 | CN1309710C Pyrimidine derivitive |
| 04/11/2007 | CN1309704C Anthranyl amides and their use as medicaments |
| 04/11/2007 | CN1309703C Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 04/11/2007 | CN1309419C A Blocking monoclonal antibody to VLA-1 and its use |
| 04/11/2007 | CN1309408C Medicine for treating parkinson's disease and Parkinson's syndrome and its prepn |
| 04/11/2007 | CN1309401C Herb medicine used for giving-up drug |
| 04/11/2007 | CN1309389C Combination of inhibiting activity of acetylcholinesterase, preparation method and application |
| 04/11/2007 | CN1309385C Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 04/11/2007 | CN1309384C 4-piperazinyl benzenesulfonyl indoles with 5-HT6 receptor affinity |
| 04/11/2007 | CN1309379C Asari dripping pills and its preparation process |
| 04/10/2007 | US7202394 Animal with the mass expression of human gene and test method by using the animal |
| 04/10/2007 | US7202381 Compounds as opioid receptor modulators |
| 04/10/2007 | US7202366 Heterocyclic analogs of diphenylethylene compounds |
| 04/10/2007 | US7202343 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 04/10/2007 | US7202331 For inducing immune response and administering immunotherapy |
| 04/10/2007 | US7202279 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| 04/10/2007 | US7202278 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; for treatment of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases |
| 04/10/2007 | US7202276 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 04/10/2007 | US7202274 Cyclic hemiacetal derivative and use thereof |
| 04/10/2007 | US7202273 Prevention of menopausal syndrome |
| 04/10/2007 | US7202268 1-Substituted with an alkylthioalkyl-, alkylsulfonylalkyl- or alkylaminosulfonylalkyl- group, e.g., 7-chloro-2-methyl-1-{3-[(methylsulfonyl)amino]-propyl}-N-[(1S)-endo-(1,3,3-trimethylbicyclo-[2.2.1]hept-2-yl)-1H-indole-3-carboxamide; cannabinoid CB2 receptor agonists |
| 04/10/2007 | US7202267 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic |
| 04/10/2007 | US7202263 [2-(Benzodioxo-5-ylalkylamino)ethoxy]-imidazol-1-yl-benzene derivatives, e.g., N-[2-(4-(imidazol-1-yl)phenoxy)ethyl]-N-[(1,3-benzodioxol-5-yl)methyl]amine; treating congestive heart failure |
| 04/10/2007 | US7202259 For prophylaxis and therapy of pain or diarrhea in an animal |
| 04/10/2007 | US7202250 2-substituted, especially 2-amino-substituted, e.g., [N-(1-ethyl)propyl]-5-(2,4-dimethoxyphenyl)-3,6-dimethylpyrazine-2-amine; bind with high affinity and high selectivity to CRF1 receptors and are used to treat central nervous system disorders |
| 04/10/2007 | US7202248 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2007 | US7202247 Such as 4-(3-(2,4-dimethoxy-5-thiophen-2-yl-phenyl)-propynoyl)-benzoic acid methyl ester; for inhibiting expression of vascular cellular adhesion molecules |
| 04/10/2007 | US7202245 Substituted 4-amino[1,2,4]triazolo[4,3-a] quinoxalines |
| 04/10/2007 | US7202243 Substituted imidazotriazines |
| 04/10/2007 | US7202242 Substituted 1 and 2-naphthol Mannich bases |
| 04/10/2007 | US7202238 Diazabicyclo alkane derivatives with NK1 antagonistic activity |
| 04/10/2007 | US7202237 Pyridylether derivatives, their preparation and use |
| 04/10/2007 | US7202236 Salts of inhibitors of trypsin-like proteases such as thrombin, e.g., a sulfonate salt of Ph(3-Cl)(5-OCHF2) (R)CH(OH)C(O) (S)Aze-Pab(OMe), combined with a cellulose ether neutral gelling polymer for the treatment or prevention of thrombosis |
| 04/10/2007 | US7202211 Methods of preventing or treating brain ischemia or brain injury |
| 04/10/2007 | US7202057 DNAs encoding rat histamine receptors of the H4 subtype |
| 04/10/2007 | US7202044 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection agents |
| 04/10/2007 | US7202040 Method for screening compounds which change the binding properties of a protein with a ligand |
| 04/10/2007 | US7201896 IL6RIL6 chimera for the treatment of neurodegenerative diseases |
| 04/10/2007 | CA2407100C 1-aroyl-piperidinyl benzamidines |
| 04/10/2007 | CA2269807C Substituted aminoalkanephosphonic acids |
| 04/10/2007 | CA2251944C Sustained release pharmaceutical compositions comprising a dibenzothiazepine derivative |
| 04/10/2007 | CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists |
| 04/10/2007 | CA2191746C [a]-annelated pyrrole derivatives and pharmaceutical use thereof |
| 04/10/2007 | CA2164276C New highly selective process for the preparation of enantiomerically pure phenylsubstituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives |
| 04/10/2007 | CA2153937C Tricyclic pyrazole derivatives |
| 04/10/2007 | CA2127084C 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-ht1a-antagonistic activity |
| 04/05/2007 | WO2007038772A1 Novel drugs for dementia |
| 04/05/2007 | WO2007038677A2 Methods for preparation of ladostigil tartrate crystalline form a1 |
| 04/05/2007 | WO2007038551A2 Use of ibudilast for treating drug and behavioral addictions |
| 04/05/2007 | WO2007038367A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof |
| 04/05/2007 | WO2007038284A1 7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]-2-(1-PROPYNYL)-7H-PYRAZOLO-[4,3-e]-[1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN-5 AMINE |
| 04/05/2007 | WO2007038271A1 Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace) |
| 04/05/2007 | WO2007038058A2 Amino-aza-adamantane derivatives and methods of use |